Pentostatin, cyclophosphamide and rituximab for previously untreated advanced stage, low-grade B-cell lymphomas-Reference-Cited by-同舟云学术

Pentostatin, cyclophosphamide and rituximab for previously untreated advanced stage, low-grade B-cell lymphomas

Published:2015-03-31 Issue:6 Volume:169 Page:814-823
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Samaniego Felipe¹,Hagemeister Fredrick¹,Romaguera Jorge E.¹,Fanale Michelle A.¹,Pro Barbara¹,McLaughlin Peter¹,Rodriguez M. Alma¹,Neelapu Sattva S.¹,Fayad Luis¹,Younes Anas¹,Feng Lei²,Berkova Zuzana¹,Khashab Tamer¹,Sehgal Lalit¹,Vega-Vasquez Francisco³,Kwak Larry W.¹

Affiliation:

1. Department of Lymphoma and Myeloma; The University of Texas MD Anderson Cancer Center; Houston TX USA

2. Department of Biostatistics; The University of Texas MD Anderson Cancer Center; Houston TX USA

3. Department of Hematopathology; The University of Texas MD Anderson Cancer Center; Houston TX USA

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bjh.13367/fullpdf

Reference30 articles.

1. Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas. NCI Sponsored International Working Group;Cheson;Journal of Clinical Oncology,1999